Football Article
Berbatov Snubs Italy For Fulham
- Author: Ben Somerford
- Sport: Soccer
- Genre: Feature
- Published: August 30, 2012
Manchester United striker Dimitar Berbatov is all set for a reunion with former boss Martin Jol and sign with Fulham for £5 million.
The Bulgarian striker has had reported interest from Italian pair Juventus and Fiorentina but will now undergo a medical with the Cottagers before completing a move to London.
Fulham have cash available with Mousa Dembele moving to Tottenham, while Clint Dempsey is set to exit before the close of the transfer window as well.
“Of course you have to pay good players good money but I think we have made steps over the last few years and there have been many clubs interested in Dimitar,” said Jol, who signed Berbatov for Tottenham from Bayer Leverkusen.
“Maybe you saw a few things on the internet, they all tried to get him but we were able and capable of getting him. Hopefully everything is good and that means we are doing the business.’’
Related news & articles
Liverpool Snubs Man City Offer
Thursday October 9
Liverpool and Spain star Fernando Torres has reportedly snubbed a big money offer from free-spending Premiership side Manchester City and has told the Eastlands clubs via his representatives that he is not even remotely interested in joining the Manchester club. More
Fulham stun Tottenham Hotspurs, push them to number four
Monday March 18
A very ordinary home performance sees Andre Villas Boas’ team drop points at home giving Chelsea a chance to capitalise on their slip and move into third. More
Sports Pundit's Fantasy Premier League Round-up
Thursday December 30
It was a busy Christmas period in the English Premier League but that also means it was a busy period of fantasy football with plenty of happenings and goings on. More
Sports Pundit's Fantasy Premier League Round-Up
Tuesday December 7
Samir Nasri stole the show with the Fantasy points this weekend, but Manchester United’s game being postponed threw plenty of coaches out. More





What's your take? Write a comment (0 comments)